Objective. To investigate whether extracellular phosphorylation of plasma proteins takes place in vivo in patients with systemic lupus erythematosus (SLE), to determine possible correlations between phosphate levels and clinical and/or laboratory parameters, and to identify individual phosphorylated plasma proteins.

Methods. Sera from SLE patients were analyzed for total amounts of protein-bound phosphate by a colorimetric technique, and for levels of β-thromboglobulin by radioimmunoassay. In addition, the ability of these sera to activate platelets, resulting in the release of protein kinase, was tested using an assay in which platelet-rich plasma from healthy blood donors was incubated with sera or immune complexes from SLE patients. In this assay, [γ-³²P]ATP was added, and ³²P-labeled C3 was quantified. Phosphate in individual proteins was detected by Western blot analysis.

Results. ³²P-labeled, activated platelets were able to phosphorylate exogenously added proteins, without the addition of ATP or cations. Platelet-rich plasma from healthy blood donors became activated by sera or by polyethylene glycol-precipitated immune complexes from patients with SLE, which led to the extracellular phosphorylation of plasma proteins, exemplified in the C3 assay. The phosphate content in plasma proteins was increased in SLE patients with previous thrombosis. The degree of phosphorylation increased up to 3-fold in serial samples obtained from 2 SLE patients during periods of disease exacerbation. Substantial phosphate increases were seen in C3 and fibrinogen. The changes were linked to platelet activation because of the observed covariation with the levels of β-thromboglobulin.

Conclusion. In SLE patients, the phosphate content in plasma proteins (including C3 and fibrinogen) increases due to platelet activation.

Reference

1 Humble E, Heldin P, Forsberg PO, Engström L: Phosphorylation in vitro of fibrinogen from three mammalian species with four different protein kinases. Arch Biochem Biophys 241: 225–231, 1985
10.1016/0003-9861(85)90378-9
CAS PubMed Web of Science® Google Scholar
2 Martin SC, Forsberg PO, Eriksson SD: The effects of in vitro phosphorylation and dephosphorylation on the thrombin-induced gelation and plasmin degradation of fibrinogen. Thromb Res 61: 243–252, 1991
10.1016/0049-3848(91)90100-B
CAS PubMed Web of Science® Google Scholar
3 Seydewitz HH, Witt I: Increased phosphorylation of human fibrinopeptide A under acute phase conditions. Thromb Res 40: 29–39, 1985
10.1016/0049-3848(85)90347-0
CAS PubMed Web of Science® Google Scholar
4 Martin SC, Ekman P, Forsberg PO, Ersmark H: Increased phosphate content of fibrinogen in vivo correlates with alteration in fibrinogen behaviour. Thromb Res 68: 467–473, 1992
10.1016/0049-3848(92)90059-J
CAS PubMed Web of Science® Google Scholar
5 Forsberg PO, Martin SC, Nilsson B, Ekman P, Nilsson UR, Engström L: In vitro phosphorylation of human complement factor C3 by protein kinase A and protein kinase C. J Biol Chem 265: 2941–2946, 1990
CAS PubMed Web of Science® Google Scholar
6 Hermoso T, Fishelson Z, Becker SI, Hirschberg K, Jaffe CL: Leishmanial protein kinases phosphorylate components of the complement system. EMBO J 10: 4061–4067, 1991
10.1002/j.1460-2075.1991.tb04982.x
CAS PubMed Web of Science® Google Scholar
7 Martin SC: Phosphorylation of complement factor C3 in vivo. Biochem J 261: 1051–1054, 1989
PubMed Web of Science® Google Scholar
8 Nilsson Ekdahl K, Nilsson B: Phosphorylation of complement component C3 and C3 fragments by a human platelet protein kinase: inhibition of factor I mediated cleavage of C3b. J Immunol 154: 6502–6510, 1995
PubMed Web of Science® Google Scholar
9 Kalafatis M, Rand MD, Jenny RJ, Ehrlich YH, Mann KG: Phosphorylation of factor Va and factor VIIIa by activated platelets. Blood 81: 704–719, 1993
CAS PubMed Web of Science® Google Scholar
10 Rand MD, Kalafatis M, Mann KG: Platelet coagulation factor Va: the major secretory platelet phosphoprotein. Blood 83: 2180–2190, 1994
10.1182/blood.V83.8.2180.2180
CAS PubMed Web of Science® Google Scholar
11 Nilsson Ekdahl K, Nilsson B: Phosphorylation of complement component C3 after synthesis in U937 cells by a putative CK2 which is regulated by CD11b. Biochem J (in press)
Google Scholar
12 Blombäck B, Blombäck M, Edman P, Hessel B: Amino-acid sequence and the occurrence of phosphorus in human fibrinopeptides. Nature 193: 883–884, 1962
10.1038/193883a0
Web of Science® Google Scholar
13 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271–1277, 1982
10.1002/art.1780251101
CAS PubMed Web of Science® Google Scholar
14 Hammer CH, Wirtz GH, Renfer L, Gresham HD, Tack BF: Large scale isolation of functionally active components of the human complement system. J Biol Chem 256: 3995–4006, 1981
10.1016/S0021-9258(19)69557-8
CAS PubMed Web of Science® Google Scholar
15 Dahlbäck B, Podack ER: Characterization of human S protein, an inhibitor of the membrane attack complex of complement: demonstration of a free reactive thiol group. Biochemistry 24: 2368–2374, 1985
10.1021/bi00330a036
CAS PubMed Web of Science® Google Scholar
16 Bittorf SV, Williams EC, Mosher DF: Alteration of vitronectin: characterization of changes induced by treatment with urea. J Biol Chem 268: 24838–24846, 1993
CAS PubMed Web of Science® Google Scholar
17 Tomasini BR, Mosher DF: Vitronectin. In, Progress in Hemostasis and Thrombosis. Edited by BS Coller. Philadelphia, WB Saunders 1991
Google Scholar
18 Nilsson B, Lööf L, Nilsson UR: Identification of a nonproteolytically activated C3 with CR 1-binding properties in sera from subjects with primary biliary cirrhosis. Int Arch Allergy Immunol 80: 312–319, 1986
10.1159/000234071
PubMed Web of Science® Google Scholar
19 Storm KE, Artursson G, Nilsson UR: Purification and characterization of porcine C3: studies of the biologically active protein and its split products. Vet Immunol Immunopathol 34: 47–61, 1992
10.1016/0165-2427(92)90151-F
CAS PubMed Web of Science® Google Scholar
20 Ekman P, Jäger O: Quantification of subnanomolar amounts of phosphate bound to seryl and threonyl residues in phosphoproteins using alkaline hydrolysis and malachite green. Anal Biochem 214: 138–141, 1993
10.1006/abio.1993.1468
CAS PubMed Web of Science® Google Scholar
21 Nilsson UR, Nilsson B: Simplified assays of hemolytic activity of the classical and alternative pathways. J Immunol Methods 72: 49–59, 1984
10.1016/0022-1759(84)90432-0
CAS PubMed Web of Science® Google Scholar
22 Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685, 1970
10.1111/j.1462-5822.2007.00901.x
CAS PubMed Web of Science® Google Scholar
23 Holmsen H, Dangelmaier CA, Akkerman JWN: Determination of levels of glycolytic intermediates and nucleotides in platelets by pulse-labeling with (32P) orthophosphate. J Biochem 131: 266–272, 1983
PubMed Web of Science® Google Scholar
24 Davey MG, Luscher EF: Release reactions of human platelets induced by thrombin and other agents. Biochim Biophys Acta 165: 490–496, 1968
10.1016/0304-4165(68)90230-4
CAS PubMed Web of Science® Google Scholar
25 Martin SC, Ekman P: In vitro phosphorylation of serum albumin by two protein kinases: a potential pitfall in protein phosphorylation reactions. Anal Biochem 154: 395–399, 1986
10.1016/0003-2697(86)90004-7
CAS PubMed Web of Science® Google Scholar
26 Born GVR, Kratzer MAA: Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J Physiol 354: 419–429, 1984
10.1113/jphysiol.1984.sp015385
CAS PubMed Web of Science® Google Scholar
27 Robey RAS: Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other “antiphospholipid” autoantibodies. Blood 9: 285–2867, 1994
Google Scholar
28 Zoli A, Zappacosta B, Altomonte L, De SP, Caricchio R, Pellegrino M, Mirone L, Giardina B, Magaro M: Platelet lactate dehydrogenase activity in systemic lupus erythematosus: correlation with anticardiolipin antibodies. J Rheumatol 22: 649–653, 1995
PubMed Web of Science® Google Scholar
29 Sims PJ, Wiedmer T: The response of human platelets to activated components of the complement system. Immunol Today 12: 338–342, 1991
10.1016/0167-5699(91)90012-I
CAS PubMed Web of Science® Google Scholar
30 Forsberg PO: Dephosphorylation of human fibrinogen, previously phosphorylated in vitro by protein kinase C, by whole blood or intestinal alkaline phosphatase. Thromb Res 53: 1–9, 1989
10.1016/0049-3848(89)90110-2
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume40, Issue12

December 1997

Pages 2178-2186

Increased phosphate content in complement component C3, fibrinogen, vitronectin, and other plasma proteins in systemic lupus erythematosus. Covariation with platelet activation and possible association with thrombosis

Abstract

Reference

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Increased phosphate content in complement component C3, fibrinogen, vitronectin, and other plasma proteins in systemic lupus erythematosus. Covariation with platelet activation and possible association with thrombosis

Abstract

Reference

Citing Literature

References

Related

Information